Valuation: Abbott Laboratories

Market Cap 198B 169B 158B 145B 272B 18,897B 276B 1,870B 729B 9,493B 742B 725B 31,399B P/E 2026 *
32.7x
P/E 2027 * 25.2x
Enterprise Value 221B 190B 177B 162B 305B 21,188B 309B 2,097B 818B 10,644B 832B 813B 35,204B EV / Sales 2026 *
4.4x
EV / Sales 2027 * 4x
Free-Float
86.16%
Yield 2026 *
2.25%
Yield 2027 * 2.4%
1 day-6.19%
1 week+12.73%
Current month+12.73%
1 month+11.71%
3 months+22.77%
6 months-8.15%
Current year-13.89%
1 week 105
Extreme 105
125.8
1 month 100
Extreme 100
125.8
Current year 90
Extreme 90
135
1 year 90
Extreme 90
144.1
3 years 90
Extreme 90
144.1
5 years 90
Extreme 90
144.1
10 years 90
Extreme 90
144.1
Manager TitleAgeSince
Chief Executive Officer 52 2020-03-30
Director of Finance/CFO 53 2023-08-31
Chief Investment Officer 51 -
Director TitleAgeSince
Director/Board Member 64 2011-12-08
Director/Board Member 67 2011-12-08
Director/Board Member 71 2017-02-15
Change 5-day change 1-year change 3-year change Capi.($)
-6.19%+12.73% - - 198B
+2.19%+4.84%-11.64%+12.29% 198B
+1.14%+2.28%+2.47%+14.39% 118B
+1.06%+1.34%+4.88%+75.73% 60.05B
-1.37%-6.27%+28.79%+60.98% 53.18B
+2.33%+4.69%-2.35%-30.34% 51.11B
+2.35%+2.89%+14.54%-11.79% 34.05B
+5.16%-4.14% - - 28.58B
-0.20%+1.05%+45.52%-10.08% 24.9B
+0.93%+1.99%-3.87%+6.81% 22.98B
Average +0.70%-0.37%+9.79%+14.75% 65.61B
Weighted average by Cap. -0.46%+0.83%+2.20%+17.57%

Financials

2026 *2027 *
Net sales 50.3B 43.09B 40.32B 36.91B 69.26B 4,813B 70.18B 476B 186B 2,418B 189B 185B 7,997B 54.65B 46.81B 43.8B 40.09B 75.24B 5,228B 76.24B 517B 202B 2,626B 205B 201B 8,687B
Net income 6.23B 5.34B 5B 4.57B 8.58B 596B 8.69B 59.02B 23.01B 300B 23.4B 22.89B 991B 7.92B 6.79B 6.35B 5.81B 10.91B 758B 11.06B 75.04B 29.26B 381B 29.76B 29.11B 1,260B
Net Debt 23.94B 20.51B 19.19B 17.56B 32.96B 2,290B 33.4B 227B 88.4B 1,151B 89.89B 87.93B 3,806B 20.96B 17.95B 16.8B 15.38B 28.86B 2,005B 29.24B 198B 77.39B 1,007B 78.69B 76.98B 3,332B
Logo Abbott Laboratories
Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - vascular devices (48.3%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - diagnostic systems and instruments (20.2%); - nutrition products (19.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (12.4%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc. Net sales are distributed geographically as follows: the United States (38.7%), Germany (6.2%), China (4.3%), India (4.2%), Switzerland (4.2%), Japan (3.3%), the United Kingdom (3%) and others (36.1%).
Employees
115,000
Date Price Change Volume
26-08-18 US$124.00 -1.43% 5
26-08-21 US$113.70 +3.36% 3
26-08-20 US$110.00 -11.29% 12
26-08-19 US$124.00 -1.43% 5
26-08-18 US$125.80 +19.81% 1
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
27
Last Close Price
114.14USD
Average target price
120.20USD
Spread / Average Target
+5.31%

Quarterly revenue - Rate of surprise